brl 42810 has been researched along with Myelodysplastic Syndromes in 2 studies
Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, Y | 1 |
| Sun, J | 1 |
| Zhang, J | 1 |
| Li, J | 1 |
| Meng, P | 1 |
| Zhou, R | 1 |
| Zhang, Y | 1 |
| Lin, Q | 1 |
2 other studies available for brl 42810 and Myelodysplastic Syndromes
| Article | Year |
|---|---|
HSV-associated erythema multiforme in a patient after hematopoietic stem cell transplantation.
Topics: Biopsy, Needle; Erythema Multiforme; Famciclovir; Follow-Up Studies; Graft vs Host Disease; Hematopo | 2019 |
Famciclovir leads to failure of hematopoiesis, but may have the benefit of relieving myeloid expansion in MDS-like zebrafish.
Topics: Animals; Animals, Genetically Modified; Antiviral Agents; Apoptosis; Famciclovir; Hematopoiesis; Hem | 2021 |